000 | 03184nam a22005295i 4500 | ||
---|---|---|---|
001 | 978-981-10-0063-8 | ||
003 | DE-He213 | ||
005 | 20200421111157.0 | ||
007 | cr nn 008mamaa | ||
008 | 160111s2016 si | s |||| 0|eng d | ||
020 |
_a9789811000638 _9978-981-10-0063-8 |
||
024 | 7 |
_a10.1007/978-981-10-0063-8 _2doi |
|
050 | 4 | _aR856-857 | |
072 | 7 |
_aMQW _2bicssc |
|
072 | 7 |
_aTEC009000 _2bisacsh |
|
082 | 0 | 4 |
_a610.28 _223 |
245 | 1 | 0 |
_aAdvances in Nanotheranostics II _h[electronic resource] : _bCancer Theranostic Nanomedicine / _cedited by Zhifei Dai. |
264 | 1 |
_aSingapore : _bSpringer Singapore : _bImprint: Springer, _c2016. |
|
300 |
_aXI, 381 p. 158 illus., 141 illus. in color. _bonline resource. |
||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
347 |
_atext file _bPDF _2rda |
||
490 | 1 |
_aSpringer Series in Biomaterials Science and Engineering, _x2195-0644 ; _v7 |
|
520 | _aThis book surveys recent advances in theranostics based on magnetic nanoparticles, ultrasound contrast agents, silica nanoparticles and polymeric micelles. It presents magnetic nanoparticles, which offer a robust tool for contrast enhanced MRI imaging, magnetic targeting, controlled drug delivery, molecular imaging guided gene therapy, magnetic hyperthermia, and controlling cell fate. Multifunctional ultrasound contrast agents have great potential in ultrasound molecular imaging, multimodal imaging, drug/gene delivery, and integrated diagnostics and therapeutics. Due to their diversity and multifunctionality, polymeric micelles and silica-based nanocomposites are highly capable of enhancing the efficacy of multimodal imaging and synergistic cancer therapy. This comprehensive book summarizes the main advances in multifunctional nanoprobes for targeted imaging and therapy of gastric cancer, and explores the clinical translational prospects and challenges. Although more research is needed to overcome the substantial obstacles that impede the development and availability of nanotheranostic products, such nontrivial nanoagents are expected to revolutionize medical treatments and help to realize the potential of personalized medicine to diagnose, treat, and follow-up patients with cancer. Zhifei Dai is a Professor at the Department of Biomedical Engineering, College of Engineering, Peking University, China. | ||
650 | 0 | _aEngineering. | |
650 | 0 | _aRadiology. | |
650 | 0 | _aOncology. | |
650 | 0 | _aBiomedical engineering. | |
650 | 0 | _aBiomaterials. | |
650 | 0 | _aNanotechnology. | |
650 | 1 | 4 | _aEngineering. |
650 | 2 | 4 | _aBiomedical Engineering. |
650 | 2 | 4 | _aNanotechnology. |
650 | 2 | 4 | _aImaging / Radiology. |
650 | 2 | 4 | _aBiomaterials. |
650 | 2 | 4 | _aOncology. |
700 | 1 |
_aDai, Zhifei. _eeditor. |
|
710 | 2 | _aSpringerLink (Online service) | |
773 | 0 | _tSpringer eBooks | |
776 | 0 | 8 |
_iPrinted edition: _z9789811000614 |
830 | 0 |
_aSpringer Series in Biomaterials Science and Engineering, _x2195-0644 ; _v7 |
|
856 | 4 | 0 | _uhttp://dx.doi.org/10.1007/978-981-10-0063-8 |
912 | _aZDB-2-ENG | ||
942 | _cEBK | ||
999 |
_c53578 _d53578 |